欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

Bipartisan Bill Would End 340B Rebate Pilot, But Is 2027 The Year For Reform?

2026-10-07
ArriVent Stumbles With Phase III Miss For Rybrevant Competitor

2026-10-07
Lupin Plans To Cut The Generic Eliquis Line In The US With Differentiated Oral Suspension

2026-10-06
U.S. Food and Drug Administration Approves Expanded Indication for Bristol Myers Squibb’s CAMZYOS® (mavacamten) for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) in Adults and Pediatric Patients*

2026-10-06
Aspen achieves Top 10 ranking for Integrated Reporting Excellence

2026-10-06
Sanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®

2026-10-06
Aurobindo Receives FDA Approval for Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg

2026-10-06
Regeneron’s Myostatin Inhibitor Preserves Muscle Mass In Phase II Obesity Study

2026-10-05
Aspen achieves Top 10 ranking for Integrated Reporting Excellence

2026-10-05
Lendava Plant Opening Boosts Sandoz’s Biosimilars Capacity

2026-10-05
News Or Promotion? Lilly’s UK Breach And Australian Guidance Draw The Line On Media Engagement

2026-10-05
Quick Listen: Scrip’s Five Must-Know Things

2026-10-05